Therapeutic potential of retroviral vectors

Transfusion Science

Volumn 17, Issue 1, 1996, Pages 7-14

  Hawley, Robert G ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA; VIRUS VECTOR;

CANCER; CONFERENCE PAPER; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC DISORDER; GENOME; LIFE CYCLE; RETROVIRUS; TARGET CELL; VIRUS RECOMBINANT;

EID: 0029984614     PISSN: 09553886     EISSN: None     Source Type: Journal    
DOI: 10.1016/0955-3886(95)00053-4     Document Type: Conference Paper

References (50)

1. Weiss RN, Teich N, Varmus H, Coffin J: RNA Tumor Viruses: Molecular Biology of Tumor Viruses, 2nd edn, 2/Supplements and Appendixes. Cold Spring Harbor, New York, Cold Spring Harbor Press, 1985.
2. Temin HM: Retrovirus variation and reverse transcription: abnormal strand transfers result in retrovirus genetic variation. Proc Natl Acad Sci USA 1993; 90:6900-6903.
3. Miller DG, Adam MA, Miller AD: Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 1990; 10:4239-4242.
4. Roe TY, Reynolds TC, Yu G, Brown PO: Integration of murine leukemia virus DNA depends on mitosis. EMBO J 1993; 12: 2099-2108.
5. Hajihosseini M, Iavachev L, Price J: Evidence that retroviruses integrate into post-replication host DNA. EMBO J 1993; 12:4969-4974.
6. Mann R, Mulligan RC, Baltimore D: Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 1983; 33:153-159.
7. Bender MA, Palmer TD, Gelinas RE, Miller AD: Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region. J Virol 1987; 61:1639-1646.
8. Armentano D, Yu SF, Kantoff PW, von Ruden T, Anderson WF, Gilboa E: Effect of internal viral sequences on the utility of retroviral vectors. J Virol 1987; 61:1647-1650.
9. Miller AD: Retroviral vectors. Curr Top Microbiol Immunol 1992; 158:1-24.
10. Kim JW, Closs EI, Albritton LM, Cunningham JM: Transport of cationic amino acids by the mouse ecotropic retrovirus receptor. Nature 1991; 352:725-728.
11. Kavanaugh MP, Miller DG, Zhang W, Law W, Kozak SL, Kabat D, Miller AD: Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci USA 1994; 91:7071-7075.
12. Miller AD, Buttimore C: Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 1986; 6:2895-2902.
13. Miller AD: Retrovirus packaging cells. Human Gene Ther 1990; 1:5-14.
14. Miller AD, Trauber DR, Buttimore, C: Factors involved in production of helper virus-free retrovirus vectors. Somatic Cell Mol Genet 1986; 12:175-183.
15. Kotani H, Newton PB III, Zhang S, Chiang YL, Otto E, Weaver L, Blaese RM, Anderson WF, McGarrity GJ: Improved methods of retroviral vector transduction and production for gene therapy. Human Gene Ther 1994; 5:19-28.
16. Southern PJ, Berg P: Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet 1982; 1:327-341.
17. Cepko CL, Roberts BE, Mulligan RC: Construction and applications of a highly transmissible murine retrovirus shuttle vector. Cell 1984; 37:1053-1062.
18. Miller AD, Rosman GJ: Improved retroviral vectors for gene transfer and expression. BioTechniques 1989; 7: 980-990.
19. Hawley TS, Burns BF, Hawley RG: Leukocytosis in mice following long-term reconstitution with genetically-modified bone marrow cells constitutively expressing interleukin-1α or interleukin-6. Leukemia Res 1991; 15:659-673.
20. Morgan RA, Couture L, Elroy-Stein O, Ragheb J, Moss B, Anderson WF: Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy. Nucl Acids Res 1992; 20:1293-1299.
21. Rosenberg SA, Aebersold P, Cornetta K, Kasid A, Morgan RA, Moen R, Karson EM, Lotze MT, Yang JC, Topalian SL, Merino MJ, Culver K, Miller AD, Blaese RM, Anderson WF: Gene transfer into humans: immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med 1990; 323:570-578.
22. Anderson WF: Human gene therapy. Science 1992; 256:808-813.
23. Miller AD: Human gene therapy comes of age. Nature 1992; 357:455-460.
24. Mulligan RC: The basic science of gene therapy. Science 1993; 260:926-932.
25. Morgan RA, Anderson WF: Human gene therapy. Ann Rev Biochem 1993; 62:191-217.
26. Sobol RE, Scalon KJ: Clinical protocols. Cancer Gene Ther 1995; 2:67-74.
27. Kessler DA, Siegel JP, Noguchi PD, Zoon KC, Feiden KL, Woodcock J: Regulation of somatic-cell therapy and gene therapy by the Food and Drug Administration. New Engl J Med 1993; 329:1169-1173.
28. Cornetta K, Morgan RA, Anderson WF: Safety issues related to retroviral-mediated gene transfer in humans. Human Gene Ther 1991; 2:5-14.
29. Finer MF, Dull TJ, Quin L, Farson D, Roberts MR: kat: a high-efficiency retroviral transduction system for primary human T lymphocytes. Blood 1994; 83:43-50.
30. Wilson C, Reitz MS, Okayama H, Eiden MV: Formation of infectious hybrid virions with gibbon ape leukemia virus and human T-cell leukemia virus retroviral envelope glycoproteins and the gag and pol genes of Moloney murine leukemia virus. J Virol 1989; 63:2374-2378.
31. Burns JC, Friedmann T, Driever W, Burrascano M, Yee J-K: Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 1993; 90:8033-8037.
32. Yee J-K, Miyanohara A, LaPorte P, Bouic K, Burns JC, Friedmann T: A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc Natl Acad Sci USA 1994; 91:9564-9568.
33. Kasahara N, Dozy AM, Kan YW: Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 1994; 266:1373-1376.
34. Lewis P, Hensel M, Emerman M: Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J 1992; 11:3053-3058.
35. Bukrinsky MI, Haggerty S, Dempsey MP, Sharova N, Adzhubel A, Spitz L, Lewis P, Goldfarb D, Emerman M, Stevenson M: A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 1993; 365:666-669.
36. + cells by a recombinant human immunodeficiency virus retroviral vector. J Clin Invest 1991; 88:1043-1047.
37. Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan R: Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 1993; 90:3539-3543.
38. Jaffee EM, Dranoff G, Cohen LK, Hauda KM, Clift S, Marshall FF, Mulligan RC, Pardoll DM: High efficiency gene transfer into primary human tumor explants without cell selection. Cancer Res 1993; 53:2221-2226.
39. Hantzopoulos PA, Sullenger BA, Ungers G, Gilboa E: Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector. Proc Natl Acad Sci USA 1989; 86:3519-3523.
40. Gansbacher B, Ziel K, Cronin K, Hantzopoulos A, Bouchard B, Houghton A, Gilboa E, Golde D: Retroviral gene transfer induced constitutive expression of IL-2 or IFN-γ in irradiated human melanoma cells. Blood 1992; 80:2817-2822.
41. Hawley RG, Lieu FHL, Fong AZC, Hawley TS: Versatile retroviral vectors for potential use in gene therapy. Gene Ther 1994; 1:136-138.
42. Hawley RG, Fong AZC, Lu M, Hawley TS: The HOX11 homeobox-containing gene of human leukemia immortalizes murine hematopoietic precursors. Oncogene 1994; 9:1-12.
43. Hawley RG, Fong AZC, Ngan B-Y, Hawley TS: Hematopoietic transforming potential of activated ras in chimeric mice. Oncogene 1995; 11:1113-1123.
44. Hawley RG, Fong AZC, Burns BF, Hawley TS: Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus. J Exp Med 1992; 176:1149-1163.
45. Hawley RG, Fong AZC, Ngan BY, de Lanux VM, Clark SC, Hawley TS: Progenitor cell hyperplasia with rare development of myeloid leukemia in interleukin-11 bone marrow chimeras. J Exp Med 1993; 178:1175-1188.
46. Hawley RG: Hematopathology of interleukin-6-type cytokines. Stem Cells 1994; 12(suppl. 1):155-171.
47. Lim B, Williams DA, Orkin SH: Retrovirus-mediated gene transfer of human adenosine deaminase: expression of functional enzyme in murine hematopoietic stem cells in vivo. Mol Cel Biol 1987; 7:3459-3465.
48. Yu SF, von Rüden T, Kantoff PW, Garber C, Seiberg M, Rüther, U, Anderson WF, Wagner EF, Gilboa E: Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc Natl Acad Sci USA 1986; 83:3194-3198.
49. Hawley RG, Covarrubias L, Hawley T, Mintz B: Handicapped retroviral vectors efficiently transduce foreign genes into hematopoietic stem cells. Proc Natl Acad Sci USA 1987; 84:2406-2410.
50. Hawley RG, Sabourin LA, Hawley TS: An improved retroviral vector for gene transfer into undifferentiated cells. Nucl Acids Res 1989; 17:4001.